[Aclarubicin-related pancreatitis in a child with AML].
Adachi
S
S
Akiyama
Y
Y
Takimoto
T
T
Tanizawa
A
A
Kiriyama
Y
Y
Kubota
Y
Y
Mikawa
H
H
D015250:Aclarubicin; D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage; D009279:Naphthacenes / Q000008:administration & dosage / Q000009:adverse effects; D010195:Pancreatitis / Q000139:chemically induced*; D014750:Vincristine / Q000008:administration & dosage
D009279:Naphthacenes; D003561:Cytarabine; D014750:Vincristine; D015250:Aclarubicin; C015019:enocitabine; D015122:Mercaptopurine